The gentlebirth.org website is provided courtesy of
Ronnie Falcao, LM MS,
a homebirth midwife in Mountain View, CA
The gentlebirth.org website is provided courtesy of
Ronnie Falcao, LM MS,
a homebirth midwife in Mountain View, CA
|
Sign MomsRising’s letter to HUD urging them to keep pushing forward on their investigations into maternal housing discrimination! Wells Fargo wants to know what’s a-brewin’ in my uterus before they make me a loan. |
From C-ap@clari.net Tue Sep 26 15:24:31 PDT 1995 Keywords: Tokos Medical Corp, tick=TKOS, Business, MedicalWASHINGTON (AP) -- The Food and Drug Administration has approved the first blood test to indicate whether a pregnant woman is about to experience preterm labor.
The test, which the FDA approved last week, detects a protein called fetal fibronectin in women who are experiencing early symptoms of preterm labor, such as backache or cramps.
After the 20th week of pregnancy, fibronectin is not supposed to be detectable in the mother's blood unless there is a problem, such as preterm labor or an infection.
The presence of fibronectin means the woman is at risk of having a premature
baby within the next two weeks and needs care to prevent that, said Tokos
Medical Corp. of Santa Ana, Calif., which holds marketing rights to the
test. It was originally developed by Adeza Biomedical Corp. of Sunnyvale,
Calif.
| About the Midwife Archives / Midwife Archives Disclaimer |